Anaptysbio ANAB
NASDAQ ANAB
$48.82 +0.19 (+0.39%)
As of: Oct 2, 2026 · 1:24 PM EDT

Anaptysbio (ANAB) Depreciation & Amortization (CF) (2016 - 2026)

Updated

Anaptysbio (ANAB) reported Depreciation & Amortization (CF) of $130,000 for Q1 2026, down 11.0% from $146,000 a year earlier and down 0.8% from the prior quarter.

Analysis

Anaptysbio (ANAB) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends

Over the twelve months ended Mar 31, 2026, Anaptysbio's Depreciation & Amortization (CF) came in at $543,000, down 7.8% year-over-year; for FY2025, it came in at $559,000, down 7.8% from FY2024.

  • Depreciation & Amortization (CF) has declined for three consecutive years, with a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $606,000 in FY2024 (-7.1%), $652,000 in FY2023 (-3.4%), $675,000 in FY2022 (+9.0%) and $619,000 in FY2021 (+10.7%).
  • The Q1 2026 figure ranks as the lowest quarterly Depreciation & Amortization (CF) since Q1 2021.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last 11 quarters, with an average decline of 8.5% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q1 2022 (growth of 29.6%); the low point was Q4 2024 (a decline of 12.1%).
  • Per Business Quant data, the three quarters before Q1 2026 came in at $131,000 (Q4 2025), $140,000 (Q3 2025) and $142,000 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Anaptysbio 1.46 Bn 346.34 Mn - 130,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 130,000.00
Dec 31, 2025 131,000.00
Sep 30, 2025 140,000.00
Jun 30, 2025 142,000.00
Mar 31, 2025 146,000.00
Dec 31, 2024 145,000.00
Sep 30, 2024 144,000.00
Jun 30, 2024 154,000.00
Mar 31, 2024 163,000.00
Dec 31, 2023 165,000.00
Sep 30, 2023 158,000.00
Jun 30, 2023 163,000.00
Mar 31, 2023 166,000.00
Dec 31, 2022 184,000.00
Sep 30, 2022 166,000.00
Jun 30, 2022 163,000.00
Mar 31, 2022 162,000.00
Dec 31, 2021 165,000.00
Sep 30, 2021 169,000.00
Jun 30, 2021 160,000.00
API Access

Anaptysbio Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ANAB&period=max&api_key=YOUR_API_KEY